MARK4 and lung carcinoma: Similarly, in the directional assay, the expression of MARK4 rescued the decrease in MDA‐MB‐231, A549 and H1299 cell migration, although this was more prominent for the lung cancer cell lines (Fig 4B and Appendix Fig S7C).